For Immediate Release
|Title:||Much-Needed Breakthrough Medical Technology Deployed for the First Time in Trinidad and Tobago|
ABC Paediatrics to be the first to unveil the device at their medical facility on 11/1/22
CARIBPR WIRE, MIAMI, FL., Thurs. October, 27, 2022: The first ever portable hematology analytical instrument by Sight Diagnostics called the OLO has been installed in the Caribbean to provide near-immediate Complete Blood Count (CBC) results to patients of Trinidad and Tobago, especially within the areas of the critically ill, oncology, and pediatrics. The CBC analyzer that accelerates the time to diagnosis and treatment will be deployed at ABC Paediatrics on November 1 at a gathering of country officials in conjunction with the medical community. This cutting-edge technology is meant to replace the bulky Flow Cytometers in low-volume and critical-need point-of-care testing (POCT) sites and settings.
A CBC test is the most elemental of medical laboratory tests and therefore, the “base camp” for diagnosing a medical condition. Up until this point, the residents of CARICOM and Trinidad and Tobago’s more remote areas had a long and involved process for getting CBC tests completed as the current method requires multiple steps, facilities, and large flow cytometer instruments at central labs. While highly accurate and fast, they proved expensive to buy and keep. With the introduction of the OLO, medical facilities won’t have to invest hundreds of thousands of dollars to acquire a flow cytometer.
The 22-pound device measuring 12.7 inches x 11.2 inches x 10 inches will bring readily available, portable, and cost-effective CBC testing without compromising the accuracy of the blood test. This device will only require two drops of blood from a finger prick of a patient aged three months or over versus the usual blood vial, though sample collection from a traditional blood collection tube is also possible. In addition, it will only take minutes to deliver results via a touchscreen interface, printout, or email.
Johann Ali, Managing Director of the distributor companies, says, “We’re known for bringing revolutionary technology to the Caribbean, and we’re incredibly honored to be involved with the distribution of the first method for ‘digitizing’ blood to the region. Sapphire Export Group is the authorized distributor in the CARICOM region, while in Trinidad and Tobago, the product will be sold through JT Rapid Diagnostics, Ltd. Both are pioneers in rapid point-of-care diagnostics in the Caribbean for more than 30 years. Making this happen will be ABC Paediatrics, a group pediatric practice in St. Augustine, Trinidad led by Dr. Leonardo Akan, who was Chief Resident at Jackson/U Health in Miami, Florida, and Dr. Tricia Jailal, who trained in the UK. Both doctors, executives from the manufacturer, and city officials will be present during the deployment, led by Sight Diagnostics, Inc. In addition, executives of Sapphire Export Group, LLC and JT Rapid Diagnostics, Ltd will be on hand for questions.
The historical deployment will take place at 10:00 am on November 1, 2022, at ABC Paediatrics #139 Eastern Main Road, St Augustine, Trinidad and Tobago. For questions contact Johann Ali, representing both distributors, by email at [email protected]
# # #
ABOUT SIGHT DIAGNOSTICS
Founded in 2011, Sight Diagnostics® is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient, and pain-free diagnostic testing. Sight’s technology, developed over almost a decade of research, represents innovations in blood sample preparation and optics, as well as advancements in chemistry, biology, physics, and computer science. Sight’s first product, Parasight ™, has been used to detect malaria in almost 1 million tests across 24 countries. Sight OLO®, Sight’s latest blood analyzer aimed at improving how Complete Blood Count (CBC) tests are performed, received FDA 510(k) clearance for use in moderately complex settings. With just 2 drops of blood obtained from a finger prick or venous sample, OLO digitizes each blood sample with more than 1,000 high-resolution images to provide accurate, lab-grade CBC results in minutes. Across Europe and the US, OLO has been adopted by both public and private healthcare institutions. Sight has also established partnerships to bring OLO to market in Asia, South America, Africa, and Australia. Sight is committed to applying its AI-based technology to transform health systems in a world where decentralized diagnostics play an increasingly important role in patient outcomes. For full indications for use and safety information, please visit https://sightdx.com/en-us.
ABOUT JT RAPID DIAGNOSTICS, LTD.
JT Rapid Diagnostics, Ltd. is a manufacturer representative focused primarily on the medical, oil and gas, and hospitality & food safety industries. JT Rapid has been a pioneer in rapid point-of-care diagnostics in the Caribbean for more than 30 years. Our founder brought modern, home-based patient-managed diabetes care to the Caribbean region in 1984, and we have led the way since. Today, we are the sole distributor of top-rated, exceptionally high-quality products for multiple points of care and critical-need areas of public and industrial health. For more info, visit https://jtrapid.com/.
ABOUT SAPHIRE EXPORT GROUP, LLC.
Sapphire Export Group is a manufacturer representative focused primarily on the medical, oil and gas, and hospitality & food safety industries, and services all of CARICOM including Antigua and Barbuda, Bahamas, Barbados, Belize, Dominica, Grenada, Guyana, Haiti, Jamaica, Montserrat, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, Anguilla, British Virgin Islands, Cayman Islands, Turks & Caicos Islands, Aruba, Curaçao and Sint Maarteen/Saint Martin.
EDITOR’S NOTE: Image for use with this article can be accessed HERE